[Uro-Vaxom治疗和预防儿童复发性尿路感染的临床评估：初步结果]
[Clinical assessment of Uro-Vaxom in the treatment and prophylaxis of recurrent urinary tract infection in children: preliminary results].
作者信息
Goszczyk A, Bochniewska V, Jung A
机构信息
Klinika Pediatrii i Nefrologii Dzieciecej Centralnego Szpitala Klinicznego Wojskowej Akademii Medycznej w Warszawie.
出版信息
Pol Merkur Lekarski. 2000 Apr;8(46):242-3.
The aim of the study was to determine the efficiency of Uro-Vaxom in the treatment of recurrent urinary tract infection in children. We examined 19 girls in aged 4-17 years treated in our Department since Jan 1998 until Jan 1999 for of recurrent urinary tract infection induced by E. coli (RUTI). All girls have been cured with Uro-Vaxom in single daily dose for 3 months. Disappearance of RUTI in 47% of children and decrease in RUTI in 42% reveals that Uro-Vaxom plays significant role in the treatment of this disease.
该研究的目的是确定优洛佳（Uro-Vaxom）治疗儿童复发性尿路感染的疗效。我们检查了自1998年1月至1999年1月在我科接受治疗的19名4至17岁因大肠杆菌引起复发性尿路感染（RUTI）的女孩。所有女孩均接受每日单次剂量的优洛佳治疗3个月，且均已治愈。47%的儿童复发性尿路感染消失，42%的儿童复发性尿路感染减少，这表明优洛佳在该疾病的治疗中发挥了重要作用。
Zotero 插件